Today's top medical abstracts
Internal Med
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Internal Med
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Internal Med
        Academic Med/Education
        Adolescent Medicine
        Allergy/Immunology
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Cardiology
        Clinical Pharmacology
        Complementary Medicine
        Critical Care/
    Hospitalist
        Dermatology
        Economics of Medicine
        Endocrinology
        Epidemiology
        Gastroenterology
        Geriatrics
        Hematology/Oncology
        Infectious Disease
        Nephrology/Urology
        Neurology
        Orthopedic/Physical Med
        Popular Press
        Preventive Medicine
        Primary Care
        Psychiatry
        Pulmonology
        Radiology/Diagnostics
        Rheumatology
        Sports Medicine
        Vascular Medicine
        Women`s Health
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
Cancer Science: #14. Does Size Matter? "Stumpy" Telomeres Allow Cancer Cells to Evade Senescence
Sara Hartley, MDLinx Oncology
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
New cancer susceptibility loci: Population and familial risks
International Journal of Cancer, 07/23/08
Print     Email This Article     Save in My Library   Free Abstract
Hemminki K et al. - In a report discussing the newly identified repertoire of cancer susceptibility genes and loci that are characterized by common risk alleles and low relative risks, it seems that in spite of the reservations for combining data on population attributable fraction (PAF) across populations, that the published first-generation genome-wide scans on breast, prostate and colorectal cancers have made successful inroads into genomics of common cancers, yet leaving the mechanisms to be explained

Methods
  • Recent large genotyping studies have identified a new repertoire of cancer susceptibility genes and loci that are characterized by common risk alleles and low relative risks
  • Because of these properties, these loci explain a much larger proportion of the etiology of the particular cancers, described by the population attributable fraction (PAF), than of their familial risks (FRRs)

Results
  • For breast cancer, 9 established loci gave a joint PAF of >60%, but explaining only some 8% of the empirical FRR
  • For prostate cancer, 6 independent loci at chromosome 8q conferred a joint PAF of 35% but the loci explained no more than 1.9% of the empirical excess familial risks
  • For colorectal cancer, the contributions of the 2 identified loci to PAF and FRR were somewhat lower
  • The genome-wide array platforms have been built for common variants, constraining the results to variants with high PAFs and low FRRs
  • Common variants are likely to tag rarer causative variants with much higher FRRs
  • Detected loci are noncoding and the underlying genetic mechanisms have not been worked out

 

Sponsor
--- HEMATOLOGY/ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.